肾透明细胞癌根治术后胰腺等多处器官转移1例

王彦文, 宋光烨, 李志鹏, 等. 肾透明细胞癌根治术后胰腺等多处器官转移1例[J]. 临床泌尿外科杂志, 2017, 32(9): 732-734. doi: 10.13201/j.issn.1001-1420.2017.09.021
引用本文: 王彦文, 宋光烨, 李志鹏, 等. 肾透明细胞癌根治术后胰腺等多处器官转移1例[J]. 临床泌尿外科杂志, 2017, 32(9): 732-734. doi: 10.13201/j.issn.1001-1420.2017.09.021

肾透明细胞癌根治术后胰腺等多处器官转移1例

详细信息
    通讯作者: 李志鹏,E-mail:lzp661021@163.com
  • 中图分类号: R737.11

  • 加载中
  • [1]

    Motzer R J, Agarwal N, Beard C, et al.Kidney cancer[J].J Natl Compr Canc Netw, 2012, 10 (4):502-535.

    [2]

    Flanigan R C, Yonover P M.The role of radical nephrectomy in metastatic renal cell carcinoma[J].Semin Urol Oncol, 2001, 19 (2):98-102.

    [3]

    Lee-Ying R, Lester R, Heng D.Current management and future perspectives of metastatic renal cell carcinoma[J].Int J Urol, 2014, 21 (9):847-855.

    [4]

    赵菊平, 何竑超, 王浩飞, 等.舒尼替尼治疗转移性肾癌的预后因素分析[J].中华泌尿外科杂志, 2015, 36 (1):7-11.

    [5]

    Zerbi A, Ortolano E, Balzano G, et al.Pancreatic metastasis from renal cell carcinoma:which patients benefit from surgical resection?[J].Ann Surg Oncol, 2008, 15 (4):1161-1168.

    [6]

    Sellner F, Tykalsky N, DE Santis M, et al.Solitary and multiple isolated metastases of clear cell renal carcinoma to the pancreas:an indication for pancreatic surgery[J].Ann Surg Oncol, 2006, 13 (1):75-85.

    [7]

    Ballarin R, Spaggiari M, Cautero N, et al.Pancreatic metastases from renal cell carcinoma:The state of the art[J].World J Gastroenterol, 2011, 17 (43):4747-4756.

    [8]

    Vincent A, Herman J, Schulick R, et al.Pancreatic cancer[J].Lancet, 2011, 378 (9791):607-620.

    [9]

    Palmowski M, Hacke N, Satzl S, et al.M etastasis to the pancreas:characterization by morphology and contrast enhancement features on CT and MRI[J].Pancreatology, 2008, 8 (2):199-203.

    [10]

    Escudier B, Porta C, Schmidinger M, et al.Renal cell carcinoma:Esmo clinical practice guidelines for diagnosis, treatment and follow-up[J].Ann Oncol, 2014, 25 Suppl 3:iii49-56.

    [11]

    Campbell S C, Flanigan R C, Clark J I.Nephrectomy in metastatic renal cell carcinoma[J].Curr Treat Option Oncol, 2003, 4 (5):363-372.

    [12]

    那彦群, 叶章群, 孙颖浩, 等.中国泌尿外科疾病诊断治疗指南 (2014版)[M].北京:人民卫生出版社, 2014:1-19.

    [13]

    Demirovi A, Cesarec S, Spaji B, et al.Can renal oncocytoma be distinguished from chromophobe renal cell carcinoma by the presence of fibrous capsule[J].Virchows Arch, 2010, 456 (1):85-89.

    [14]

    那彦群, 叶章群, 孙颖浩, 等.中国泌尿外科疾病诊断治疗指南手册 (2014版)[M].北京:人民卫生出版社, 2014:16.

    [15]

    Reeves D J, Liu C Y.Treatment of metastatic renal cell cacinoma[J].Cancer Chemother Pharmacol, 2009, 64 (1):11-25.

    [16]

    孙伟, 杨斌, 郑军华.肾细胞癌靶向治疗预后相关因素研究进展[J].临床泌尿外科杂志, 2013, 28 (10), 793-797.

    [17]

    Motzer R J, Hutson T E, Tomczak P, et al.Sunitinib versus interferon alfa in metastatic renal-cell carcinoma[J].N Engl J Med, 2007, 356 (2):115-124.

    [18]

    Borregales L D, Adibi M, Thomas A Z, et al.The role of neoadjuvant therapy in the management of locally advanced renal cell carcinoma[J].Ther Adv Urol, 2016, 8 (2):130-141.

  • 加载中
计量
  • 文章访问数:  250
  • PDF下载数:  776
  • 施引文献:  0
出版历程
收稿日期:  2016-11-30

目录